Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Defining NASH from a multi-omics systems biology perspective

    Research output: Contribution to journalReviewResearchpeer-review

  2. Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Corticosteroid Resistance in Smokers-A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Language Development for the New Generation of Children with Hearing Impairment

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence of Pathogenic Germline DICER1 Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Classification of MSH6 Variants of Uncertain Significance Using Functional Assays

    Research output: Contribution to journalReviewResearchpeer-review

  4. Genomforskningsprojekt påviser TP53-mutation hos en pige med rabdomyosarkom

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Mev Dominguez-Valentin
  • John-Paul Plazzer
  • Julian R Sampson
  • Christoph Engel
  • Stefan Aretz
  • Mark A Jenkins
  • Lone Sunde
  • Inge Bernstein
  • Gabriel Capella
  • Francesc Balaguer
  • Finlay Macrae
  • Ingrid M Winship
  • Huw Thomas
  • Dafydd Gareth Evans
  • John Burn
  • Marc Greenblatt
  • Wouter H de Vos Tot Nederveen Cappel
  • Rolf H Sijmons
  • Maartje Nielsen
  • Lucio Bertario
  • Bernardo Bonanni
  • Maria Grazia Tibiletti
  • Giulia Martina Cavestro
  • Annika Lindblom
  • Adriana Della Valle
  • Francisco Lopez-Kostner
  • Karin Alvarez
  • Nathan Gluck
  • Lior Katz
  • Karl Heinimann
  • Carlos A Vaccaro
  • Sigve Nakken
  • Eivind Hovig
  • Kate Green
  • Fiona Lalloo
  • James Hill
  • Hans F A Vasen
  • Claudia Perne
  • Reinhard Büttner
  • Heike Görgens
  • Elke Holinski-Feder
  • Monika Morak
  • Stefanie Holzapfel
  • Robert Hüneburg
  • Magnus von Knebel Doeberitz
  • Markus Loeffler
  • Nils Rahner
  • Jürgen Weitz
  • Verena Steinke-Lange
  • Wolff Schmiegel
  • Deepak Vangala
  • Emma J Crosbie
  • Marta Pineda
  • Matilde Navarro
  • Joan Brunet
  • Leticia Moreira
  • Ariadna Sánchez
  • Miquel Serra-Burriel
  • Miriam Mints
  • Revital Kariv
  • Guy Rosner
  • Tamara Alejandra Piñero
  • Walter Hernán Pavicic
  • Pablo Kalfayan
  • Sanne W Ten Broeke
  • Jukka-Pekka Mecklin
  • Kirsi Pylvänäinen
  • Laura Renkonen-Sinisalo
  • Anna Lepistö
  • Päivi Peltomäki
  • John L Hopper
  • Aung Ko Win
  • Daniel D Buchanan
  • Noralane M Lindor
  • Steven Gallinger
  • Loïc Le Marchand
  • Polly A Newcomb
  • Jane C Figueiredo
  • Stephen N Thibodeau
  • Christina Therkildsen
  • Thomas V O Hansen
  • Lars Lindberg
  • Einar Andreas Rødland
  • Florencia Neffa
  • Patricia Esperon
  • Douglas Tjandra
  • Gabriela Möslein
  • Toni T Seppälä
  • Pål Møller
View graph of relations

BACKGROUND: Lynch syndrome is the most common genetic predisposition for hereditary cancer. Carriers of pathogenic changes in mismatch repair (MMR) genes have an increased risk of developing colorectal (CRC), endometrial, ovarian, urinary tract, prostate, and other cancers, depending on which gene is malfunctioning. In Lynch syndrome, differences in cancer incidence (penetrance) according to the gene involved have led to the stratification of cancer surveillance. By contrast, any differences in penetrance determined by the type of pathogenic variant remain unknown.

OBJECTIVE: To determine cumulative incidences of cancer in carriers of truncating and missense or aberrant splicing pathogenic variants of the MLH1 and MSH2 genes.

METHODS: Carriers of pathogenic variants of MLH1 (path_MLH1) and MSH2 (path_MSH2) genes filed in the Prospective Lynch Syndrome Database (PLSD) were categorized as truncating or missense/aberrant splicing according to the InSiGHT criteria for pathogenicity.

RESULTS: Among 5199 carriers, 1045 had missense or aberrant splicing variants, and 3930 had truncating variants. Prospective observation years for the two groups were 8205 and 34,141 years, respectively, after which there were no significant differences in incidences for cancer overall or for colorectal cancer or endometrial cancers separately.

CONCLUSION: Truncating and missense or aberrant splicing pathogenic variants were associated with similar average cumulative incidences of cancer in carriers of path MLH1 and path_MSH2.

Original languageEnglish
Article number2856
JournalJournal of Clinical Medicine
Volume10
Issue number13
Pages (from-to)1-12
Number of pages12
ISSN2077-0383
DOIs
Publication statusPublished - 28 Jun 2021

    Research areas

  • Lynch syndrome, MLH1, MSH2, aberrant splicing, cancer incidence, missense, penetrance, truncating, Aberrant splicing, Truncating, Penetrance, Cancer incidence, Missense

ID: 66573271